NT
NTC Pharma
Florence ITFounded 200630 employees
Private CapbiotechPrivateInfectious Disease
Platform: Anti-infective
Market Cap
N/A
All Drugs
4
Clinical Trials
6
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| NTC-7741 | NTC-7741 | NDA/BLA | 2 | JAK2 | WMCSU | ||
| Liralemzoparlimab | NTC-4118 | Phase 3 | 2 | PI3Kα | AngelmanCKD | ||
| Mirisacituzumab | NTC-2471 | NDA/BLA | 1 | SOS1 | EpilepsyBreast Ca | ||
| NTC-6338 | NTC-6338 | Approved | 1 | FXIa | ASCeliac |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)